세계의 RNAi 기술 시장 보고서(2025년)

Ribonucleic acid interference (RNAi) technology is a biological mechanism that regulates gene expression by using small RNA molecules to silence specific messenger RNA (mRNA) sequences. By controlling gene activity, it enables scientists to suppress or reduce the production of targeted proteins. This makes RNAi a powerful tool for inhibiting disease-related genes and supports genetic research, drug development, and therapeutic applications.

The main products in ribonucleic acid interference (RNAi) technology include micro ribonucleic acid (miRNA), small interfering ribonucleic acid (siRNA), and others. Micro ribonucleic acid (miRNA) consists of short, non-coding RNA molecules that bind to complementary mRNA sequences to block translation or promote degradation, thereby fine-tuning gene expression. Delivery methods include viral vectors, nanoparticles, chemical modifications, and physical techniques, with applications across therapeutics, drug discovery, agriculture, and diagnostics. RNAi technology is widely used by pharmaceutical and biotechnology companies, academic and research institutions, and contract research organizations (CROs) and contract manufacturing organizations (CMOs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The ribonucleic acid interference (RNAi) technology market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid interference (RNAi) technology market statistics, including ribonucleic acid interference (RNAi) technology industry global market size, regional shares, competitors with a ribonucleic acid interference (RNAi) technology market share, detailed ribonucleic acid interference (RNAi) technology market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid interference (RNAi) technology industry. This ribonucleic acid interference (RNAi) technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ribonucleic acid interference (RNAi) technology market size has grown rapidly in recent years. It will grow from $3.82 billion in 2024 to $4.43 billion in 2025 at a compound annual growth rate (CAGR) of 16.1%. Growth in the historic period can be attributed to increasing funding for genomics research, the rising prevalence of genetic and rare diseases, greater use of RNA interference in functional genomics studies, growing pharmaceutical interest in gene-silencing technologies, and expanding academic-industry collaborations.

The ribonucleic acid interference (RNAi) technology market size is expected to see rapid growth in the next few years. It will grow to $7.96 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%. Growth in the forecast period can be attributed to a rise in clinical trial initiations and patient enrollment, increasing partnerships, mergers, and licensing agreements, growing healthcare spending on specialty and precision medicines, rising demand for personalized therapies, and the increasing burden of oncology and chronic liver diseases. Major trends expected in the forecast period include advancements in lipid nanoparticle delivery systems, development of N-acetylgalactosamine (GalNAc)-conjugate liver-targeting technologies, optimization of self-delivering siRNA platforms, artificial-intelligence-assisted design and off-target reduction for siRNA, and progress in exosome-mediated and cell-penetrating peptide-based delivery methods.

The increasing demand for targeted therapeutics is expected to drive the growth of the ribonucleic acid interference (RNAi) technology market in the coming years. Targeted therapies are designed to specifically target and inhibit molecular abnormalities in diseases such as cancer, improving treatment precision and minimizing harm to healthy cells. The rising emphasis on targeted therapies is primarily fueled by advancements in precision medicine, which enable personalized treatments based on an individual's genetic profile. RNAi technology plays a crucial role in this shift, enabling precise gene silencing to treat genetic and rare diseases. It supports the development of highly specific and effective treatments, spurring innovation in personalized medicine. For example, in December 2024, the American Society of Gene & Cell Therapy (ASGCT) reported that the U.S. Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, up from 5 approvals in 2022. Therefore, the growing demand for targeted therapeutics is driving the expansion of the RNAi technology market.

Key players in the RNAi technology market are focusing on platform integration and securing strategic funding to streamline the development, delivery, and commercialization of RNAi therapeutics, ensuring a sustainable pipeline of programs across various disease areas. Strategic funding refers to securing investment from venture capital, industry partners, and other stakeholders to accelerate the research and development of RNAi-based medicines. For instance, in October 2024, City Therapeutics Inc., a US-based biopharmaceutical company, raised $135 million in Series A financing, led by ARCH Venture Partners with participation from other major life sciences investors. This funding will help develop RNAi-based medicines using the company's proprietary lipid nanoparticle (LNP) delivery platform, which is designed to target tissues beyond the liver with high precision. This innovation aims to address a historical limitation in the RNAi field, enabling the development of therapies for a broader range of genetic disorders.

In July 2023, Novartis AG, a Swiss pharmaceutical company, acquired DTx Pharma Inc. for an undisclosed amount. This acquisition aims to strengthen Novartis' RNAi therapeutic capabilities and expand its neuromuscular disease portfolio through DTx Pharma's FALCON delivery platform. DTx Pharma, a US-based preclinical-stage biotechnology company, specializes in RNA interference technology for the development of RNAi-based therapeutics.

Major companies operating in the ribonucleic acid interference (rnai) technology market are F. Hoffmann-La Roche AG, Merck KGaA, Novartis AG, Thermo Fisher Scientific Inc., Danaher Corporation, Revvity Inc., QIAGEN N.V., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., GenScript Biotech Corporation, Promega Corporation, Arrowhead Pharmaceuticals Inc., Silence Therapeutics plc, Creative Biolabs Inc., Bioneer Corporation, Genevant Sciences Ltd., Gradalis Inc., Altogen Labs LLC, Sirnaomics Inc., Altogen Biosystems Inc.

North America was the largest region in the ribonucleic acid interference (RNAi) technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ribonucleic acid interference (RNAi) technology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ribonucleic acid interference (RNAi) technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ribonucleic acid interference (RNAi) technology consists of revenues earned by entities by providing services such as gene silencing services, custom ribonucleic acid (RNA) synthesis, oligonucleotide design, ribonucleic acid (RNA) sequencing, target validation, functional genomics screening, data analysis, drug discovery support, delivery system optimization, and molecular assay development. The market value includes the value of related goods sold by the service provider or included within the service offering. The RNA interference (RNAi) technology market also includes sales of microRNA mimics, transfection reagents, ribonucleic acid (RNA) delivery kits, plasmid vectors, assay kits, cell lines, reagents and buffers, and laboratory consumables. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ribonucleic Acid Interference (RNAi) Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ribonucleic acid interference (rnai) technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ribonucleic acid interference (rnai) technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid interference (rnai) technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Micro Ribonucleic Acid (miRNA); Small Interfering Ribonucleic Acid (siRNA); Other Products
• 2) By Delivery Method: Viral Vectors; Nanoparticles; Chemical Modifications; Physical Methods
• 3) By Application: Therapeutics; Drug Discovery; Agriculture; Diagnostics
• 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs)
• Subsegments:
• 1) By Micro Ribonucleic Acid (miRNA): Micro Ribonucleic Acid Mimics; Micro Ribonucleic Acid Inhibitors; Micro Ribonucleic Acid Expression Vectors; Micro Ribonucleic Acid Profiling And Quantification Kits
• 2) By Small Interfering Ribonucleic Acid (siRNA): Small Interfering Ribonucleic Acid Synthetic Duplexes; Small Interfering Ribonucleic Acid Dicer Substrate Molecules; Small Interfering Ribonucleic Acid Self Delivering Conjugates; Small Interfering Ribonucleic Acid N Acetylgalactosamine Conjugates
• 3) By Other Products: Short Hairpin Ribonucleic Acid Expression Constructs; Ribonucleic Acid Interference Screening Libraries; Ribonucleic Acid Interference Transfection Reagents; Micro Ribonucleic Acid And Small Interfering Ribonucleic Acid Research Kits
• Companies Mentioned: F. Hoffmann-La Roche AG; Merck KGaA; Novartis AG; Thermo Fisher Scientific Inc.; Danaher Corporation; Revvity Inc.; QIAGEN N.V.; Alnylam Pharmaceuticals Inc.; Ionis Pharmaceuticals Inc.; GenScript Biotech Corporation; Promega Corporation; Arrowhead Pharmaceuticals Inc.; Silence Therapeutics plc; Creative Biolabs Inc.; Bioneer Corporation; Genevant Sciences Ltd.; Gradalis Inc.; Altogen Labs LLC; Sirnaomics Inc.; Altogen Biosystems Inc.
• Countries:

Table of Contents

1. Executive Summary

2. Ribonucleic Acid Interference (RNAi) Technology Market Characteristics

3. Ribonucleic Acid Interference (RNAi) Technology Market Trends And Strategies

4. Ribonucleic Acid Interference (RNAi) Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Ribonucleic Acid Interference (RNAi) Technology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Ribonucleic Acid Interference (RNAi) Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Ribonucleic Acid Interference (RNAi) Technology Market Growth Rate Analysis
• 5.4. Global Ribonucleic Acid Interference (RNAi) Technology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Ribonucleic Acid Interference (RNAi) Technology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Ribonucleic Acid Interference (RNAi) Technology Total Addressable Market (TAM)

6. Ribonucleic Acid Interference (RNAi) Technology Market Segmentation

• 6.1. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Micro Ribonucleic Acid (miRNA)
• Small Interfering Ribonucleic Acid (siRNA)
• Other Products
• 6.2. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral Vectors
• Nanoparticles
• Chemical Modifications
• Physical Methods
• 6.3. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutics
• Drug Discovery
• Agriculture
• Diagnostics
• 6.4. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Academic And Research Institutes
• Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs)
• 6.5. Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Micro Ribonucleic Acid (miRNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Micro Ribonucleic Acid Mimics
• Micro Ribonucleic Acid Inhibitors
• Micro Ribonucleic Acid Expression Vectors
• Micro Ribonucleic Acid Profiling And Quantification Kits
• 6.6. Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Small Interfering Ribonucleic Acid (siRNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Interfering Ribonucleic Acid Synthetic Duplexes
• Small Interfering Ribonucleic Acid Dicer Substrate Molecules
• Small Interfering Ribonucleic Acid Self Delivering Conjugates
• Small Interfering Ribonucleic Acid N Acetylgalactosamine Conjugates
• 6.7. Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Short Hairpin Ribonucleic Acid Expression Constructs
• Ribonucleic Acid Interference Screening Libraries
• Ribonucleic Acid Interference Transfection Reagents
• Micro Ribonucleic Acid And Small Interfering Ribonucleic Acid Research Kits

7. Ribonucleic Acid Interference (RNAi) Technology Market Regional And Country Analysis

• 7.1. Global Ribonucleic Acid Interference (RNAi) Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Ribonucleic Acid Interference (RNAi) Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ribonucleic Acid Interference (RNAi) Technology Market

• 8.1. Asia-Pacific Ribonucleic Acid Interference (RNAi) Technology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ribonucleic Acid Interference (RNAi) Technology Market

• 9.1. China Ribonucleic Acid Interference (RNAi) Technology Market Overview
• 9.2. China Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ribonucleic Acid Interference (RNAi) Technology Market

• 10.1. India Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ribonucleic Acid Interference (RNAi) Technology Market

• 11.1. Japan Ribonucleic Acid Interference (RNAi) Technology Market Overview
• 11.2. Japan Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ribonucleic Acid Interference (RNAi) Technology Market

• 12.1. Australia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ribonucleic Acid Interference (RNAi) Technology Market

• 13.1. Indonesia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ribonucleic Acid Interference (RNAi) Technology Market

• 14.1. South Korea Ribonucleic Acid Interference (RNAi) Technology Market Overview
• 14.2. South Korea Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market

• 15.1. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market Overview
• 15.2. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ribonucleic Acid Interference (RNAi) Technology Market

• 16.1. UK Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ribonucleic Acid Interference (RNAi) Technology Market

• 17.1. Germany Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ribonucleic Acid Interference (RNAi) Technology Market

• 18.1. France Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ribonucleic Acid Interference (RNAi) Technology Market

• 19.1. Italy Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ribonucleic Acid Interference (RNAi) Technology Market

• 20.1. Spain Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market

• 21.1. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market Overview
• 21.2. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ribonucleic Acid Interference (RNAi) Technology Market

• 22.1. Russia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ribonucleic Acid Interference (RNAi) Technology Market

• 23.1. North America Ribonucleic Acid Interference (RNAi) Technology Market Overview
• 23.2. North America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ribonucleic Acid Interference (RNAi) Technology Market

• 24.1. USA Ribonucleic Acid Interference (RNAi) Technology Market Overview
• 24.2. USA Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ribonucleic Acid Interference (RNAi) Technology Market

• 25.1. Canada Ribonucleic Acid Interference (RNAi) Technology Market Overview
• 25.2. Canada Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ribonucleic Acid Interference (RNAi) Technology Market

• 26.1. South America Ribonucleic Acid Interference (RNAi) Technology Market Overview
• 26.2. South America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ribonucleic Acid Interference (RNAi) Technology Market

• 27.1. Brazil Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ribonucleic Acid Interference (RNAi) Technology Market

• 28.1. Middle East Ribonucleic Acid Interference (RNAi) Technology Market Overview
• 28.2. Middle East Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ribonucleic Acid Interference (RNAi) Technology Market

• 29.1. Africa Ribonucleic Acid Interference (RNAi) Technology Market Overview
• 29.2. Africa Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ribonucleic Acid Interference (RNAi) Technology Market Competitive Landscape And Company Profiles

• 30.1. Ribonucleic Acid Interference (RNAi) Technology Market Competitive Landscape
• 30.2. Ribonucleic Acid Interference (RNAi) Technology Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Ribonucleic Acid Interference (RNAi) Technology Market Other Major And Innovative Companies

• 31.1. Revvity Inc.
• 31.2. QIAGEN N.V.
• 31.3. Alnylam Pharmaceuticals Inc.
• 31.4. Ionis Pharmaceuticals Inc.
• 31.5. GenScript Biotech Corporation
• 31.6. Promega Corporation
• 31.7. Arrowhead Pharmaceuticals Inc.
• 31.8. Silence Therapeutics plc
• 31.9. Creative Biolabs Inc.
• 31.10. Bioneer Corporation
• 31.11. Genevant Sciences Ltd.
• 31.12. Gradalis Inc.
• 31.13. Altogen Labs LLC
• 31.14. Sirnaomics Inc.
• 31.15. Altogen Biosystems Inc.

32. Global Ribonucleic Acid Interference (RNAi) Technology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ribonucleic Acid Interference (RNAi) Technology Market

34. Recent Developments In The Ribonucleic Acid Interference (RNAi) Technology Market

35. Ribonucleic Acid Interference (RNAi) Technology Market High Potential Countries, Segments and Strategies

• 35.1 Ribonucleic Acid Interference (RNAi) Technology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Ribonucleic Acid Interference (RNAi) Technology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Ribonucleic Acid Interference (RNAi) Technology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer